America's aging population, GenAI RCM and more interesting stuff.

Healthcare through a Kentucky lens. It's niche. But neat!

Author

Andrew Steen
December 30, 2025

2025 ➡️ 2026

Aging baby boomers

“By the end of this decade, all baby boomers will be 65 and older, and the number of people 80 and over will double in 20 years…”

A look at aging baby boomers in the United States

The oldest baby boomers are turning 80 in 2026. This generation known as a cultural and political vanguard is now contributing to America's aging population.

apnews.com/article/census-baby-boomers-aging-america-demographics-ad275e223615952ce73d52ed714d24b0?utm_source=copy&utm_medium=share

It’s a demographic hard to ignore.

Elder care innovation

Chia-Lin Simmons is CEO of LogicMark, Inc. LogicMark’s principal executive offices are in—wait for it—Louisville, KY.

The greatest threat to elder care isn’t what you think 

Yes, we are living in an era of astonishing transformation. Technology is reshaping nearly every corner of our lives — from how we work and communicate to how we diagnose disease, manage cities and care for people with a variety of conditions. Two major shifts that affect everyone are converging simultaneously: the explosive growth of artificial intelligence in healthcare and the rapid aging of the global population.

www.mcknightshomecare.com/the-greatest-threat-to-elder-care-isnt-what-you-think

While we’re on Louisville-based companies…

This Fierce Healthcare article references a survey by the Healthcare Financial Management Association and AKASA on GenAI-powered tools for revenue cycle management. Among other things, the survey notes that “Health systems executives also reported lack of a clear return on investment.”

Adoption of AI for hospital RCM surges, but cost, operational constraints slow progress

Health systems are eager to adopt generative artificial intelligence solutions for revenue cycle management, seeing the promise of the technology to improve coding and capture more revenue. | Many health systems remain in the early stages of adoption, citing cost and budget constraints as the largest obstacles as providers bump into the realities of implementing new AI technologies at scale.

www.fiercehealthcare.com/ai-and-machine-learning/adoption-ai-hospital-rcm-surges-even-health-systems-navigate-cost

I asked John Williamson, Founder and CEO of Louisville-based Lockbox AI, Inc. for his thoughts. “I think the gap in ROI realization is because there are still the same number of FTEs involved in delivering a service, plus the very high technology cost. The reason is because the LLM approach often requires a human review, even if it was faster. The frontier of cost savings is a combination of automation orchestration that links across multiple point solutions and process requirements. Companies that provide tech-enabled service delivery are still outperforming pure-play software as a service vendors.”

So where is Lockbox AI headed? 🥁 roll, please.

“We’ve got a SaaS solution but are officially about to launch an automation enabled service.

We’re finding that providing a turnkey service is more attractive than just offering software. The ROI is much more clear and it’s an easier purchase process.”

You read it here first. Maybe.

A predictions piece I like

The whole piece is worth a read. But I’m digging the section on “Screening, diagnostics, and at-home sample collection becomes the hot area” because, yeah, I agree.

Out-Of-Pocket’s 2026 Predictions | Out-Of-Pocket

Foundation model JVs, C-SNPs, peptide crackdown

www.outofpocket.health/p/out-of-pockets-2026-predictions?ck_subscriber_id=2439033429&utm_source=convertkit&utm_medium=email&utm_campaign=2026%20Predictions:%20AI,%20peptides,%20C-SNPs%20and%20more%20-%2020200522&sh_kit=28675b01443415006a4b50f65d9fe032970d6dd1d6dd4f657f8810276ee2d2d5#screening-diagnostics-and-at-home-sample-collection-becomes-the-hot-area

Oh, and remember—biologistics. We do that relatively well in Louisville.

The FDA is seeking information from VC firms

Kind of interesting.

“The FDA recognizes that many breakthrough technologies and innovative solutions relevant to our public health mission are being developed by companies within VC portfolios.”

FDA Explores New Contracting Approach to Advance Public Health Innovation

The U.S. Food and Drug Administration has issued a Request for Information (RFI) seeking input from venture capital firms on developing a new contracting approach to strengthen collaboration between the agency and America’s most innovative companies.

www.fda.gov/news-events/press-announcements/fda-explores-new-contracting-approach-advance-public-health-innovation

I was dreamin' when I wrote this
Forgive me if it goes astray

Don’t wait til it’s 2026
Subscribe and share today.